CR-UK/Prostate Cancer UK, ICGC, The PPCG 2022, ' Rare Germline Variants Are Associated with Rapid Biochemical Recurrence After Radical Prostate Cancer Treatment : A Pan Prostate Cancer Group Study ', European Urology . https://doi.org/10.1016/j.eururo.2022.05.007 Burns, D, Anokian, E, Saunders, E J, Bristow, R G, Fraser, M, Reimand, J, Schlomm, T, Sauter, G, Brors, B, Korbel, J, Weischenfeldt, J, Waszak, S M, Corcoran, N M, Jung, C H, Pope, B J, Hovens, C M, Cancel-Tassin, G, Cussenot, O, Loda, M, Sander, C, Hayes, V M, Dalsgaard Sorensen, K, Lu, Y J, Hamdy, F C, Foster, C S, Gnanapragasam, V, Butler, A, Lynch, A G, Massie, C E, Woodcock, D J, Cooper, C S, Wedge, D C, Brewer, D S, Kote-Jarai, Z, Eeles, R A & CR-UK/Prostate Cancer UK, ICGC, The PPCG 2022, ' Rare Germline Variants Are Associated with Rapid Biochemical Recurrence After Radical Prostate Cancer Treatment : A Pan Prostate Cancer Group Study ', European Urology, vol. 82, no. 2, pp. 201-211 . https://doi.org/10.1016/j.eururo.2022.05.007
Prostate Cancer and Prostatic Diseases Ahmed, M, Goh, C, Saunders, E, Cieza-Borrella, C, Kote-Jarai, Z, Schumacher, F R, Eeles, R & The PRACTICAL Consortium 2020, ' Germline genetic variation in prostate susceptibility does not predict outcomes in the chemoprevention trials PCPT and SELECT ', Prostate Cancer and Prostatic Diseases, vol. 23, no. 2, pp. 333-342 . https://doi.org/10.1038/s41391-019-0181-y